| Ytd | -42.28% | |
| 1y | -26.06% |
| Open | 27.20 | Prev Close | 27.20 | Low | 26.38 | High | 27.30 | Mkt Cap | 866.95M |
| Vol | 576.04K | Avg Vol | 448.50K | EPS | 7.97 | P/E | 3.35 | Forward P/E | 4.86 |
| Beta | 0.73 | Short Ratio | 11.92 | Inst. Own | 128.23% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-06 | 50-d Avg | 34.58 | 200-d Avg | 39.28 | 1yr Est | 53.60 |
Collegium Pharmaceutical, Inc. (COLL) Q2 2026 Earnings Call Transcript
Although the revenue and EPS for Collegium Pharmaceutical (COLL) give a sense of how its business pe
Collegium Pharmaceutical (COLL) came out with quarterly earnings of $1.92 per share, beating the Zac
Collegium Pharmaceutical NASDAQ: COLL reported second-quarter 2026 net product revenue of $199.9 mil
– Completed Acquisition of AZSTARYS ® , Strengthening ADHD Portfolio and Extending Long-Term Revenue
Collegium Pharmaceutical (COLL) is transitioning from a pain-management roll-up to a CNS platform, l
STOUGHTON, Mass., July 23, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a
Bessemer Group Inc. grew its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ: COLL) by 48.
BOSTON--(BUSINESS WIRE)--DivcoWest, a DivCore Capital company and national commercial real estate in
STOUGHTON, Mass., July 20, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) a
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
COLL, IRWD, AMTB and DUK stand out as defensive stock picks as investors rotate from AI-driven tech
BBCP, KUBTY, ADM, COLL and W have been added to the Zacks Rank #1 (Strong Buy) List on July 6, 2026.
COLL gains momentum as strong Jornay PM growth and the Azstarys acquisition boosted 2026 guidance, s
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and
STOUGHTON, Mass. , June 05, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) t
STOUGHTON, Mass., May 27, 2026 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) tod
- Adds Highly Complementary and Differentiated Medicine with Significant Growth Potential to Collegi
Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings
Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is estimated to report quarterly loss a
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnin
Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnin
Companies Reporting Before The Bell • Toyota Motor (NYSE:TM) is projected to report earnings for
On Wednesday, 807 companies reached new 52-week lows.
Companies Reporting Before The Bell • The Middleby (NASDAQ:MIDD) is expected to report quarterly
During Wednesday's trading, 435 companies set new 52-week lows.
During Thursday, 849 stocks hit new 52-week lows.
Wednesday's session saw 784 companies set new 52-week lows.
Companies Reporting Before The Bell • DISH Network (NASDAQ:DISH) is likely to report quarterly e
Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report q
Companies Reporting Before The Bell • ViacomCBS (NASDAQ:VIAC) is projected to report quarterly e
Companies Reporting Before The Bell • PG&E (NYSE:PCG) is likely to report quarterly earnings
This morning 533 companies reached new 52-week highs.
On Tuesday, 596 companies set new 52-week highs.
Companies Reporting Before The Bell • Bluerock Residential Growth REIT, Inc. Class A Common Stoc
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Wednesday
Stocks That Hit 52-Week Highs On Friday
Stocks That Hit 52-Week Highs On Thursday
Stocks That Hit 52-Week Highs On Friday